IRIS
LANZILLOTTA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 831
NA - Nord America 396
AS - Asia 315
OC - Oceania 9
SA - Sud America 6
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.560
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 432
US - Stati Uniti d'America 392
SE - Svezia 238
CN - Cina 158
SG - Singapore 113
RU - Federazione Russa 71
FI - Finlandia 32
DE - Germania 17
IN - India 16
GB - Regno Unito 12
IE - Irlanda 10
NZ - Nuova Zelanda 7
PE - Perù 6
TR - Turchia 6
CA - Canada 4
HK - Hong Kong 4
PH - Filippine 4
IL - Israele 3
PK - Pakistan 3
UA - Ucraina 3
AL - Albania 2
AU - Australia 2
CH - Svizzera 2
ES - Italia 2
FR - Francia 2
GR - Grecia 2
IR - Iran 2
JP - Giappone 2
LV - Lettonia 2
NL - Olanda 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
CZ - Repubblica Ceca 1
EU - Europa 1
KR - Corea 1
LK - Sri Lanka 1
RO - Romania 1
TW - Taiwan 1
Totale 1.560
Salva come PNG Salva come JPEG
Città #
Shanghai 81
Lawrence 69
Princeton 69
Singapore 69
Milan 54
New York 46
Moscow 41
Ashburn 34
Rome 34
Helsinki 30
Boardman 28
Pune 15
Cagliari 13
Seattle 13
Turin 13
Rovigo 10
Dublin 9
Galliate 9
London 9
Vaprio d'Adda 8
Verona 8
Bari 7
Dallas 6
Florence 6
Naples 6
Auckland 5
Bergamo 5
Jiaxing 5
Mezzolombardo 5
Mira 5
Vittoria 5
Alessandria 4
Beijing 4
Borås 4
Genoa 4
Istanbul 4
Los Angeles 4
Mantova 4
Minerbio 4
Miraflores District 4
Monza 4
Quezon City 4
Sesto San Giovanni 4
Trino 4
Angera 3
Barletta 3
Gallarate 3
Kyiv 3
Monte 3
Padova 3
Parma 3
Piana degli Albanesi 3
Portoferraio 3
Quanzhou 3
Salt Lake City 3
San Lazzaro di Savena 3
Shenzhen 3
Siena 3
Vimercate 3
Xi'an 3
Ancona 2
Andover 2
Athens 2
Atlanta 2
Bacoli 2
Benken 2
Bologna 2
Brescia 2
Calci 2
Campobasso 2
Casoria 2
Castel Madama 2
Cermenate 2
Corbola 2
Cosenza 2
Duino-Aurisina 2
Feilding 2
Frankfurt am Main 2
Guangzhou 2
Hong Kong 2
Islamabad 2
Lanciano 2
Lenta 2
Livorno 2
Ljungby 2
Madrid 2
Melbourne 2
Messina 2
Munich 2
Parabiago 2
Pedrengo 2
Pesaro 2
Pescara 2
Portogruaro 2
Ravenna 2
Reggio Emilia 2
Riga 2
Rimini 2
Rozzano 2
Secaucus 2
Totale 897
Salva come PNG Salva come JPEG
Nome #
PACHIMENINGITE IPERTROFICA IGG4-CORRELATA: DIAGNOSI E RISPOSTA TERAPEUTICA 234
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 49
Dupilumab as a potential steroid-sparing treatment for IgG4-related disease. 45
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 41
IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients 36
IMMUNOTERAPIA SPECIFICA E MALATTIA IgG4-CORRELATA: STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO 36
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 34
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 30
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 28
A cd8 alpha-negative subset of cd4+slamf7+ cytotoxic t cells is expanded in patients with igg4-related disease and decreases following glucocorticoid treatment 27
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 27
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 26
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 25
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 25
A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment 24
Advances in the diagnosis and management of IgG4 related disease. 24
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study 23
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 23
A unique case of IgG4-related pachymeningitis treated with intrathecal rituximab 22
EFFETTI DEL PREDNISONE SULLE SOTTOPOPOLAZIONI B LINFOCITARIE NEI PAZIENTI CON MALATTIA IgG4-CORRELATA 22
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 22
Methotrexate as induction of remission therapy for localized manifestations of IgG4-Related Disease. 22
Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers. 21
B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma 21
ASSOCIAZIONE TRA MALATTIA IGG4-CORRELATA E IMMUNOTERAPIA ALLERGENE-SPECIFICA. STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO. 21
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED DISEASE 21
IDENTIFICAZIONE DI UNA SOTTOPOPOLAZIONE CD8- DI LINFOCITI CD4 CITOTOSSICI ESPANSA NEI PAZIENTI CON MALATTIA IGG4-CORRELATA E RESPONSIVA ALLA TERAPIA CON GLUCOCORTICOIDI 21
B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. 21
Urgent manifestations of immunoglobulin G4-related disease 20
Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease 19
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 19
INFLAMMATORY ACTIVITY OF IgG4-RELATED DISEASE LESIONS ASSESSED BY QUANTITATIVE POSITRON EMISSION TOMOGRAPHY CORRELATES WITH CIRCULATING PLASMABLASTS LEVELS 19
Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: A case report and review of the literature. 18
IGG4 RELATED HYPERTROPHIC PACHYMENINGITIS: DIAGNOSTIC APPROACH AND THERAPEUTIC OUTCOMES 18
CLINICAL PHENOTYPES OF IGG4- RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL FEATURES, SEROLOGICAL FINDINGS,AND PROGNOSTIC OUTCOMES 18
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis 17
INCREASE OF CIRCULATING MEMORY B CELLS AFTER GLUCOCORTICOID-INDUCED REMISSION PREDICTS IGG4-RELATED DISEASE RELAPSE 17
Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept study 16
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 16
IGG4 RELATED HYPERTROPHIC PACHYMENINGITIS: DIAGNOSTIC APPROACH AND THERAPEUTIC OUTCOMES 16
METHOTREXATE AS INDUCTION OF REMISSION THERAPY FOR LOCALIZED MANIFESTATIONS OF IGG4-RELATED DISEASE 16
Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease 16
Igg4-related disease of the oral cavity. Case series from a large single-center cohort of italian patients 15
EFFECTS OF GLUCOCORTICOIDS AND METHOTREXATE-BASED THERAPEUTIC REGIMENS ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 15
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circula-ting plasmablasts in IgG4-related type 1 au-toimmune pancreatitis and other organs 15
MALATTIA IGG4-CORRELATA: ESPERIENZA QUINQUENNALE MONOCENTRICA SU UNA CORTE ITALIANA DI 150 PAZIENTI (2013 - 2018) 15
Effects Of Glucocorticoids On B Cell Subpopulations In Patients With IgG4-Related type I autoimmune pancreatitis 15
Mer tyrosine kinase as a possible link between resolution of inflammation and tissue fibrosis in IgG4-related disease 15
Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis 14
LONG-TERM EFFICACY OF RITUXIMAB MAINTENANCE THERAPY FOR IGG4- RELATED DISEASE RITUXIMAB MAINTENANCE THERAPY IN IGG4-RELATED DISEASE 14
EFFICACY AND SAFETY OF RITUXIMAB FOR INDUCTION OF REMISSION AND MAINTENANCE OF IGG4-RELATED DISEASE: EXPERIENCE FROM AN ITALIAN NATIONAL REFERRAL CENTRE 14
CLINICAL MANIFESTATIONS OF IGG4-RELATED DISEASE ONSET REQUIRE ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES. EXPERIENCE FROM A SINGLE ITALIAN REFERRAL CENTRE 14
EFFETTI DELLA TERAPIA CON PREDNISONE E METHOTREXATE SULLE SOTTOPOPOLAZIONI B LINFOCITARIE NEI PAZIENTI AFFETTI DA MALATTIA-IgG4 CORRELATA 14
Role of systemic immunosuppression on subglottic stenosis in granulomatosis with polyangiitis: Analysis of a single-centre cohort 13
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease 13
CLINICAL PHENOTYPES OF IGG4-RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL, IMMUNOLOGICAL AND PROGNOSTIC FEATURES 13
EFFECTS OF COMBINED THERAPY WITH PREDNISONE AND METHOTREXATE ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 13
MERTK AND THE RESOLUTION OF INFLAMMATION IN IGG4-RELATED DISEASE 13
CIRCULATING PLASMABLASTS LEVELS REFLECT INFLAMMATORY ACTIVITY IN IGG4-RELATED DISEASE LESIONS AS ASSESSED BY QUANTITATIVE POSITRON EMISSION TOMOGRAPHY 12
METHOTREXATE AS INDUCTION OF REMISSION THERAPY FOR LOCALIZED MANIFESTATIONS OF IGG4-RELATED DISEASE 12
FENOTIPI CLINICI DELLA MALATTIA IGG4 CORRELATA: ANALISI CROSS-SECTIONAL DI UNA CORTE INTERNAZIONALE 12
An International, Multi-Specialty Validation Study of the IgG4-Related Disease Responder Index 12
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19 12
Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: A European multi-centre study 11
Methotrexate as Induction of Remission Therapy for Type 1 Autoimmune Pancreatitis 11
Association of IgG4-related disease and systemic rheumatic disorders 10
Methotrexate as induction of remission the-rapy for IgG4-Related type 1 Autoimmune Pancreatitis 10
Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center 9
Serum IgG4 elevation in hyper-inflamed COVID-19 patients. Author's reply 9
EFFECTS OF COMBINED THERAPY WITH PREDNISONE AND METHOTREXATE ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 9
IGG4-RELATED DISEASE IN ITALY: RESULTS FROM A MONOCENTRIC COHORT OF 150 PATIENTS (2013–2018) 9
DECONSTRUCTING LA MALATTIA DA IGG4 CON INTERESSAMENTO DELLE STRUTTURE MEDIANE: CONFRONTO CON I COMUNI “MIMICKERS” 9
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. 9
IgG4-RELATED DISEASE PRESENTATION REQUIRES ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES 9
Serum IgG4 level predicts COVID-19 related mortality 8
Immunology of IgG4-related disease 8
Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis 7
Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse 7
EFFICACIA E SICUREZZA DELLA SOMMINISTRAZIONE INTRATECALE DI RITUXIMAB PER IgG4-RELATED PACHIMENINGITE IPERTROFICA REFRATTARIA 6
Roles of Plasmablasts and B Cells in IgG4-Related Disease: Implications for Therapy and Early Treatment Outcomes 6
Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment 6
HLA-DRB1∗16 and -DQB1∗05 alleles are strongly associated with autoimmune pancreatitis in a cohort of hundred patients 6
Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease 5
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. 5
Totale 1.670
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.086
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.086
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 7 0 0 0 0 0
2020/202121 1 0 1 4 1 8 0 1 1 1 2 1
2021/2022156 0 0 46 12 2 10 7 9 21 15 18 16
2022/2023546 170 93 42 6 12 54 53 40 33 5 12 26
2023/2024593 26 39 69 46 38 88 22 69 6 24 61 105
2024/2025341 139 57 51 50 44 0 0 0 0 0 0 0
Totale 1.670